HIPERTENSAO ARTERIAL EM PACIENTES OBESOS COM HIPERTROFIA CARDIACA. EFEITOS DO CAPTOPRIL SOBRE A SENSIBILIDADE A INSULINA E HORMONIO DE CRESCIMENTO

Purpose. To evaluate the effects of captopril (Cpt) on carbohydrate metabolism and growth hormone (GH) in adults hypertensive obese patients with normal (NGT) or impaired (IGT) glucose tolerance and left ventricular hypertrophy. Methods. Ten patients (53 ± 8 years), 8 women and 2 men, white, body ma...

Descripción completa

Detalles Bibliográficos
Autores: Velasco-Conejo, I. F. [UNESP], Martin, Luis Cuadrado [UNESP], Brandao-Neto, J. [UNESP], Marchioli, M. [UNESP], De Barros e Silva, M. [UNESP], De Cassia Athanazio-Heliodoro, R. [UNESP], Da Silva Franco, R. J. [UNESP]
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:1995
País:Brasil
Institución:Universidade Estadual Paulista (UNESP)
Repositorio:Repositório Institucional da UNESP
Idioma:portugués
OAI Identifier:oai:repositorio.unesp.br:11449/64559
Acceso en línea:http://www.arquivosonline.com.br/pesquisartigos/Pdfs/1995/V64N2/64020007.pdf
http://hdl.handle.net/11449/64559
Access Level:acceso abierto
Palabra clave:captopril
glucose tolerance
growth hormone
insulin
antihypertensive agent
lipid
adult
blood pressure
carbohydrate metabolism
clinical article
clinical trial
female
heart hypertrophy
heart left ventricle hypertrophy
human
hypertension
insulin sensitivity
male
obesity
aged
blood
glucose blood level
glucose intolerance
glucose tolerance test
insulin resistance
time
Adult
Aged
Antihypertensive Agents
Blood Glucose
Captopril
English Abstract
Female
Glucose Intolerance
Glucose Tolerance Test
Growth Hormone
Human
Hypertension
Hypertrophy, Left Ventricular
Insulin
Insulin Resistance
Lipids
Male
Middle Age
Obesity
Support, Non-U.S. Gov't
Time Factors
Descripción
Sumario:Purpose. To evaluate the effects of captopril (Cpt) on carbohydrate metabolism and growth hormone (GH) in adults hypertensive obese patients with normal (NGT) or impaired (IGT) glucose tolerance and left ventricular hypertrophy. Methods. Ten patients (53 ± 8 years), 8 women and 2 men, white, body mass index (BMI) ≥ 26 kg/m2, left ventricular mass index (LVMI) > 135 g/m2 in man and > 110 g/m2 in woman, with diastolic blood pressure (DBP) 95-115 mmHg after 3 weeks of placebo, were identified by oral glucose tolerance test (OGTT-75 g) as either with NGT or IGT, and treated with Cpt 25 mg t.i.d. for 8 weeks. At the 8 weeks, dosage was increased to 50 mg b.i.d. if DBP > 90 mmHg or the decrease of the DBP < 10%, during the next 8 weeks. OGTT and clonidine tests (0,04 mg/kg) with determinations, every 30 minutes of glucose, insulin, and GH during 2 hours, were performed. Results. Cpt lowered SBP and DBP in the NGT group and IGT group. The LVMI and the left ventricular mass (LVM) decreased in the IGT group with no significant change in the NGT group. Cpt promoted in the IGT group decrease in the area under the curve (AUC) of glucose, and AUC of insulin, with increase of the AUC of the percent of the β cell function, AUC of HC, and insulin sensitivity index with no significantly change in the NGT group. Conclusion. Adults hypertensive obese patients with IGT had decreased significantly in mean fasting level of GH concentrations compared to age, race, and BMI matched hypertensive patients with NGT. Treatment with Cpt induced a significant increased of the GH, with improvement of the metabolism in patients with IGT.